Eledon Pharmaceuticals
ELDN
ELDN
32 hedge funds and large institutions have $48.2M invested in Eledon Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7.77% more ownership
Funds ownership: 39.65% → 47.42% (+7.8%)
Holders
32
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$5.57M | |
| 2 | +$5.19M | |
| 3 | +$3.83M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.42M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.58M |
Top Sellers
| 1 | -$206K | |
| 2 | -$32.9K | |
| 3 | -$28.6K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$389 |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$45 |